Bioventus Inc.
BVS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001665988
No open-market purchases or sales by Bioventus Inc. insiders were filed in the last 90 days; 156 institutions reported holding it in 13F filings for Q2 2026, worth $566.0M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 156
- 13F valueReported value at the end of Q2 2026
- $566.0M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BVS, Q2 2026
No superinvestor reported holding BVS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Bioventus Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 (view filing) | Mar 11 | 2 days | McMurry-Heath MichelleDirector | SSaleClass A Common Stock | −12.0K | $8.79 | −$105.5K | −21.1%45.0K after | |
| Dec 8, 2025 (view filing) | Dec 4 | 4 days | Nohra Guy PDirector | SSaleClass A Common Stock | −10.0K | $7.57 | −$75.7K | −7.9%116.6K after | |
| Nov 10, 2025 (view filing) | Nov 7 | 3 days | McMurry-Heath MichelleDirector | SSaleClass A Common Stock | −17.7K | $7.42 | −$131.3K | −23.7%57.0K after | |
| Apr 15, 2025 (view filing) | Apr 11 | 4 days | Singleton Mark LeonardSVP & CFO | SSaleClass A Common Stock | −3.88K | $7.57 | −$29.3K | −2.7%141.1K after | 10b5-1 |
| Apr 15, 2025 (view filing) | Apr 11 | 4 days | D'Adamio AnthonySVP & General Counsel | SSaleClass A Common Stock | −2.96K | $7.57 | −$22.4K | −2.2%131.4K after | 10b5-1 |
| Apr 15, 2025 (view filing) | Apr 11 | 4 days | Church Katrina JSVP & Chief Compliance Officer | SSaleClass A Common Stock | −1.28K | $7.57 | −$9.71K | −2.3%55.6K after | 10b5-1 |
| Mar 25, 2025 (view filing) | Mar 24 | 1 day | Singleton Mark LeonardSVP & CFO | SSaleClass A Common Stock | −5.48K | $9.79 | −$53.6K | −4.0%132.0K after | 10b5-1 |
| Mar 18, 2025 (view filing) | Mar 17 | 1 day | Church Katrina JSVP & Chief Compliance Officer | SSaleClass A Common Stock | −1.02K | $9.75 | −$9.93K | −1.9%52.5K after | 10b5-1 |
| Mar 18, 2025 (view filing) | Mar 17 | 1 day | D'Adamio AnthonySVP & General Counsel | SSaleClass A Common Stock | −2.62K | $9.75 | −$25.5K | −2.1%124.4K after | 10b5-1 |
| Feb 20, 2025 (view filing) | Feb 18 | 2 days | Singleton Mark LeonardSVP & CFO | SSaleClass A Common Stock | −6.50K | $10.19 | −$66.2K | −5.2%118.8K after | 10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Bioventus Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 13,021,324 | $122.9M | 48.35% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 12,000,558 | $113.3M | 3.43% | +5,878,155+96.0% | Added |
| Juniper Investment Company, LLC | 6,939,357 | $65.5M | 17.35% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,435,914 | $32.4M | 0.00% | +302,373+9.6% | Added |
| Royce & Associates LP | 1,833,212 | $17.3M | 0.14% | +291,930+18.9% | Added |
| Vanguard Capital Management LLC | 1,751,678 | $16.5M | 0.00% | +36,971+2.2% | Added |
| Geode Capital Management, LLC | 1,365,716 | $12.9M | 0.00% | +197,469+16.9% | Added |
| American Century Companies Inc | 1,353,415 | $12.8M | 0.01% | +733,612+118.4% | Added |
| Dimensional Fund Advisors LP | 1,128,465 | $10.7M | 0.00% | +255,327+29.2% | Added |
| State Street Corp | 1,104,878 | $10.4M | 0.00% | +116,511+11.8% | Added |